Stock comparison
Arbutus Biopharma
ABUS$892.87MHealthcare Market cap, Sector
Jeena Sikho Lifecare Limited
JSLL.BO$71.28BHealthcare Market cap, Sector
Overall winner
Jeena Sikho Lifecare Limited
ABUS 16 JSLL.BO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
ABUS1wins
6winsJSLL.BO
49D
B84
43F
A87
55D
A92
48D
C66
100A
B75
64C
A91
66C
A95
Side-by-side metrics
| Metric | ABUS | JSLL.BO |
|---|---|---|
| Market cap | $892.87M | $71.28B Winner |
| P/E (TTM) | Winner: 5.1x | 33.2x |
| EV/EBIT | Winner: - | 24.1x |
| ROIC (TTM) | Winner: 56.72% | 39.15% |
| Gross margin | Winner: 99.98% | 88.58% |
| Net margin | Winner: 83.95% | 27.68% |
| Revenue CAGR 5y | 6.4% | 57.81% Winner |
| EPS CAGR 5y | - | 86.67% |
| Debt / Equity | Winner: 0.0x | 0.3x |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ABUS leads on
- EV/EBIT-vs 24.1x+181%
- Debt / Equity0.0xvs 0.3x+99%
- P/E (TTM)5.1xvs 33.2x+85%
- Net margin83.95%vs 27.68%+67%
JSLL.BO leads on
- Market cap$71.28Bvs $892.87M+99%
- Revenue CAGR 5y57.81%vs 6.4%+89%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.